Comparison of physician-authored and artificial intelligence-generated after-visit summaries: A blinded comparative s…

🤖 Generated with AI assistance · Does not replace individualized medical advice.

AI-Generated Discharge Summaries Outperform Physician-Authored Versions in Blinded Oncology-Adjacent Study

AI Transparency Notice: This post was curated and synthesized by an AI assistant to summarize published medical literature. It is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for clinical decisions.

Lead

In a blinded comparative study of 50 hospitalized adults, LLM-generated after-visit summaries (AVSs) using GPT-4 and Gemma 3n significantly outperformed physician-authored documents in understandability, actionability, and safety metrics PMID: 42703807.

Key Facts

Metric GPT-4 Gemma 3n Physician-Authored
PEMAT Understandability 85.5% PMID: 42703807 87.5% PMID: 42703807 66.1% PMID: 42703807
PEMAT Actionability 70.9% PMID: 42703807 74.1% PMID: 42703807 56.7% PMID: 42703807
AVSrubric Overall Higher PMID: 42703807 Higher PMID: 42703807 Baseline PMID: 42703807
Potential for Harm Lower PMID: 42703807 Lower PMID: 42703807 Higher PMID: 42703807

Why It Matters / Context

Discharge documentation is a critical safety checkpoint in oncology and general hospital medicine. Poorly written after-visit summaries (AVSs) are a known contributor to readmissions, medication errors, and patient confusion, particularly for complex regimens like chemotherapy or immunotherapy. Historically, AVSs have been criticized for being written above the average patient’s literacy level and for omitting actionable next steps due to clinician time constraints PMID: 42703807.

This study addresses the “last mile” of patient communication. By leveraging Large Language Models (LLMs) to translate complex hospital courses into sixth-grade-level, patient-centered language, the research suggests a viable workflow to reduce clinician burden while enhancing patient safety. For oncologists, this implies that AI-assisted documentation could standardize the clarity of discharge instructions, ensuring patients understand critical follow-up appointments, side effect management, and warning signs without requiring additional physician time.

Details

The study conducted a retrospective, blinded comparison of 50 adults discharged from the University of California San Diego Health hospital medicine service in 2023 PMID: 42703807. The physician-authored hospital course served as the source text for generating AVSs using two distinct models: GPT-4 and Gemma 3n PMID: 42703807. Both models were prompted to produce sixth-grade level, patient-centered AVSs PMID: 42703807.

Five attending physicians independently evaluated each AVS using two validated instruments:

1. Patient Education Materials Assessment Tool (PEMAT): Assessed understandability and actionability.

2. AVSrubric: Assessed accuracy, comprehensiveness, clarity, consistency with the medical record, tone/empathy, and potential for harm.

Comparative Performance

Domain GPT-4 Performance Gemma 3n Performance Physician-Authored Performance Statistical Significance
Understandability (PEMAT) 85.5% PMID: 42703807 87.5% PMID: 42703807 66.1% PMID: 42703807 All p < .001 PMID: 42703807
Actionability (PEMAT) 70.9% PMID: 42703807 74.1% PMID: 42703807 56.7% PMID: 42703807 All p < .001 PMID: 42703807
AVSrubric: Accuracy Higher PMID: 42703807 Higher PMID: 42703807 Baseline PMID: 42703807 GPT-4 significant PMID: 42703807
AVSrubric: Comprehensiveness Higher PMID: 42703807 Higher PMID: 42703807 Baseline PMID: 42703807 GPT-4 significant PMID: 42703807
AVSrubric: Clarity Higher PMID: 42703807 Higher PMID: 42703807 Baseline PMID: 42703807 Both significant PMID: 42703807
AVSrubric: Tone/Empathy Higher PMID: 42703807 Higher PMID: 42703807 Baseline PMID: 42703807 Both significant PMID: 42703807
Potential for Harm Lower PMID: 42703807 Lower PMID: 42703807 Higher PMID: 42703807 Associated with lower harm PMID: 42703807

GPT-4 demonstrated significantly higher ratings than physician-authored AVSs across all five AVSrubric domains PMID: 42703807. Gemma 3n showed significant improvements in clarity, readability, tone, and empathy, though the abstract notes GPT-4 was superior in all five domains PMID: 42703807.

Limitations

Critical Appraisal:

* Small Sample Size: The study included only 50 patients, limiting statistical power and generalizability PMID: 42703807.

* Retrospective Design: The data was collected retrospectively from 2023, which may not reflect current LLM capabilities or evolving clinical workflows PMID: 42703807.

* Evaluator Bias: While blinded, the evaluators were attending physicians, not patients. Patient perception of “understandability” may differ from physician assessment PMID: 42703807.

* Lack of Oncology-Specific Data: The study focused on general hospital medicine. Oncology discharges involve complex chemotherapy regimens, toxicity management, and survivorship care plans that may present unique challenges for LLMs not captured in this cohort PMID: 42703807.

* No Prospective Safety Data: The study measured “potential for harm” via rubric, not actual adverse events or readmission rates PMID: 42703807.

Clinical Takeaway

Implementing a physician-in-the-loop LLM workflow for generating after-visit summaries may improve discharge communication clarity and reduce clinician burden, warranting prospective evaluation in oncology settings.

Full Reference

Kviatkovsky M, Stewart C, McDonald A, Xing Y, Gianella S, Gelberg A. Comparison of physician-authored and artificial intelligence-generated after-visit summaries: A blinded comparative study. Journal of Hospital Medicine. 2026. PMID: 42703807 [DOI: 10.1002/jhm.70435]